(PRWEB) October 16, 2012
The latest in an ongoing series of scientific meetings on preventive cardiology through public awareness and early detection of atherosclerosis, the symposium includes many of the most recognized investigators, clinicians and academicians in the field.
Those presenting and moderating include Dr. Valentin Fuster, Dr. Matthew Budoff, Dr. Taseem Naqvi, Dr. Jagat Narula, Dr. Erling Falk, Dr. Daniel Berman, Dr. Raimund Erbel, Dr. Robert Superko, Dr. Harvey Hecht and Dr. Morteza Naghavi.
For more information and to register to attend this breakthrough event, go to the Society's website: http://www.shapesociety.org or call 713-529-4484.
2012 SHAPE Summit
Updates on Cardiovascular Risk Assessment in the Asymptomatic Population –
Searching for the “Vulnerable Patient”
November 2, 2012, From 7:00am to 11:00am
Thalians Auditorium, Cedars-Sinai Medical Center
8730 Alden Drive, Plaza Level, Los Angeles, CA 90048
Daniel Berman, M.D., Jagat Narula, M.D., PK Shah, M.D.
Friday, November 2, 2012
7:00 am Breakfast
7:15 am Welcome:
Morteza Naghavi, M.D., the Founder of SHAPE and Executive Chairman of the
SHAPE Task Force
7:30 am Featured Lecture:
What to expect for asymptomatic CVD risk assessment in the next 5 years.
Valentin Fuster, M.D., Ph.D.
8:00 am Latest developments in non-invasive imaging of atherosclerosis using coronary calcium (15-minute talk + discussion)
Matthew Budoff, M.D.
8:20 am Latest developments in non-invasive imaging of atherosclerosis using carotid ultrasound - CIMT and plaque (15-minute talk + discussion)
Tasneem Naqvi, M.D.
8:40 am Latest developments in non-invasive coronary CT angiography
(15-minute talk + discussion)
Jagat Narula, M.D.
9:00 am BREAK
9:20 am Lessons learned and to be learned from the HRP bio-image study
Erling Falk, M.D., Ph.D.
9:40 am Lessons learned from the EISNER study
Daniel Berman, M.D.
10:00 am Lessons learned from the Heinz Nixdorf RECALL study
Raimund Erbel, M.D.
10:20 am Planned NIH study: comparing SHAPE with status quo
Matthew Budoff, M.D.
10:40 am What is the role of biomarkers and genomics in prevention?
H. Robert Superko, M.D.
11:00 am Adjourning SHAPE Summit
To view videos of interviews with SHAPE Task Force participants visit: http://www.youtube.com/view_play_list?p=1B0A14FAB1DBDAE5.